Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Erin, Joseph"'
Autor:
John S. Lazo, Robert A. Parise, Erin Joseph, Julie L. Eiseman, Jianxia Guo, Merrill J. Egorin, Edward V. Prochownik
Publikováno v:
Cancer Chemotherapy and Pharmacology. 63:615-625
c-Myc is commonly activated in many human tumors and is functionally important in cellular proliferation, differentiation, apoptosis and cell cycle progression. The activity of c-Myc requires noncovalent interaction with its client protein Max. In vi
Autor:
Laura L. Jung, Julie L. Eiseman, William C. Zamboni, Sandra Strychor, Sarah A. Fetterman, Beth A. Zamboni, Erin Joseph, Dennis P. Curran, Thomas G. Burke, Brian Sidone
Publikováno v:
Investigational New Drugs. 26:399-406
Purpose: DB-67 is a silatecan, 7-silyl-modified camptothecin, with enhanced lipophilicity and increased blood stability of the active-lactone ring. The generation of a liposomal formulation of DB-67 may be an attractive method of intravenous (IV) adm
Publikováno v:
Journal of Photochemistry and Photobiology B: Biology. 88:90-104
Efficient design of anti-cancer treatments involving radiation- and photo-sensitizing therapeutics requires knowledge of tissue-specific drug concentrations. This study investigates the use of the optical pharmacokinetic system (OPS) to measure conce
Autor:
Robert A. Parise, Jan H. Beumer, Joseph M. Covey, Julie L. Eiseman, Erin Joseph, Merrill J. Egorin
Publikováno v:
Rapid Communications in Mass Spectrometry. 21:1991-1997
A number of anticancer drugs are cytidine analogues that undergo metabolic deactivation catalyzed by cytidine deaminase (CD). 3,4,5,6-Tetrahydrouridine (THU) is a potent inhibitor of CD, by acting as a transition-state analogue of its natural substra
Autor:
Joseph M. Covey, Robert S. Parker, Erin Joseph, Jan H. Beumer, Merrill J. Egorin, Julie L. Eiseman, David Z. D'Argenio
Publikováno v:
Clinical Cancer Research. 12:5826-5833
Purpose: To elucidate the in vivo metabolic fate of zebularine (NSC 309132), a DNA methyltransferase inhibitor proposed for clinical evaluation in the treatment of cancer. Experimental Design: Male, CD2F1 mice were dosed i.v. with 100 mg/kg 2-[14C]ze
Autor:
Merrill J. Egorin, Sandra Strychor, Ramesh K. Ramanathan, William C. Zamboni, Julie L. Eiseman, Erin Joseph, Laura L. Jung, Deborah R. Hamburger, Ruzhi Jin
Publikováno v:
Clinical Cancer Research. 11:4867-4874
9-Nitrocamptothecin has completed phase III studies in patients with newly diagnosed and refractory pancreatic cancer; however, the optimal 9-nitrocamptothecin treatment regimen is unclear. We used an intermittent schedule of 9-nitrocamptothecin to e
Autor:
Alexander V. Lyubimov, Joseph M. Covey, Ya Fei Chen, Julie L. Eiseman, Julianne L. Holleran, Erin Joseph, Robert A. Parise, Merrill J. Egorin, Elizabeth R. Glaze, David Z. D'Argenio
Publikováno v:
Clinical Cancer Research. 11:3862-3868
Purpose: Zebularine is a DNA methyltransferase inhibitor proposed for clinical evaluation. Experimental Design: We developed a liquid chromatography/mass spectrometry assay and did i.v. and oral studies in mice, rats, and rhesus monkeys. Results: In
Autor:
Julie L. Eiseman, Guozhang Zhu, Donald J. Creighton, Erin Joseph, Heekyung Tak, Zhe-Bin Zheng
Publikováno v:
Bioconjugate Chemistry. 16:598-607
The incorporation of anticancer prodrugs into polyacrylamide conjugates has been shown to improve tumor targeting via the so-called "enhanced permeability and retention" effect. This strategy has now been expanded to include two different classes of
Autor:
J. T. Mondick, Tushar S. Garimella, Julie L. Eiseman, Kenneth S. Bauer, Takeo Nakanishi, Erin Joseph, Douglas D. Ross, Susan E. Bates
Publikováno v:
Cancer Chemotherapy and Pharmacology. 55:101-109
Multidrug resistance (MDR) remains a major obstacle in the treatment of human cancers. The recently discovered breast cancer resistance protein (BCRP/ABCG2) has been found to be an important mediator of chemotherapeutic MDR. Fumitremorgin C (FTC) is
Autor:
Merrill J. Egorin, Clive Brown-Proctor, Paul E. Kinahan, Chester A. Mathis, Jerry M. Collins, Deborah R. Hamburger, Julie L. Eiseman, Erin Joseph, Raymond W. Klecker, Lawrence W. Anderson, Su-Shu Pan
Publikováno v:
Clinical Cancer Research. 10:6669-6676
Purpose: In colorectal, breast, and head and neck cancers, response to 5-fluorouracil is associated with low expression of thymidylate synthase. In contrast, tumors with high expression of thymidylate synthase may be more sensitive to prodrugs such a